• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ONYX AVM; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ONYX AVM; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number 105-7100-060
Device Problem Entrapment of Device (1212)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/04/2024
Event Type  malfunction  
Manufacturer Narrative
Associated with uf/importer rpt num: 1001510000-2024-8003 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received a report that an echelon catheter had fractured.The patient was undergoing treatment for transarterial embolization of the occipital artery.Distal access into the right occipital artery was obtained with an echelon microcatheter.The microcatheter run demonstrated good po sitioning of the microcatheter.The catheter was then flushed with dmso and onyx 18 was then slowly injected under constant fluoroscopic guidance utilizing a blank road map.Three vials of onyx 18 were used with care to avoid reflux as they embolized back to the i ntermediate catheter.Periodic runs were performed confirming progressive embolization with significant reduction in supply to the fistula.At this point the elected to conclude the procedure and performed a staged approach to treatment of the complex fistula with multiple feeders.We attempted to withdraw the microcatheter however there was significant resistance and ultimately the catheter fractured.Remnant catheter was observed within the intermediate catheter down into the common carotid artery.They attempted to use a guidewire to push the remnant catheter up into the occipital artery however, the wire was sliding past the catheter.The pxs slim microcatheter was then introduced into the sofia and occipital artery.And the wire used to push out the echelon 10 microcatheter which was noted to be coiled in the occipital artery.Final runs were performed demonstrating no evidence of any thromboembolic complications and decreased filling of the fistula.There were no patient symptoms or complications associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX AVM
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18893222
MDR Text Key337654313
Report Number2029214-2024-00418
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 03/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number105-7100-060
Device Catalogue Number105-7100-060
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/26/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age65 YR
Patient Weight102 KG
Patient RaceWhite
-
-